NMRD (Nemaura Medical) Total Receivables: $0.42 Mil (As of Dec. 2023)


What is Nemaura Medical Total Receivables?

Nemaura Medical NMRD Total Receivables is $0.42 Mil as of Dec. 2023.

Nemaura Medical's Total Receivables for the quarter that ended in Dec. 2023 was $0.42 Mil.

Nemaura Medical Total Receivables Related Terms

Nemaura Medical Total Receivables Historical Data

* Premium members only.

The historical data trend for Nemaura Medical's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nemaura Medical Total Receivables Chart

Nemaura Medical Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.10 0.09 0.36 0.41

Nemaura Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.24 0.41 0.72 0.49 0.42

Nemaura Medical Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $0.42 Mil mean?
Nemaura Medical (NMRD) has a Total Receivables of $0.42 Mil as of Dec. 2023. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Nemaura Medical and its competitors.
Is Nemaura Medical's Total Receivables too high?
Nemaura Medical's current Total Receivables is $0.42 Mil.
How does Nemaura Medical's Total Receivables compare to THMO and MOTS?
Nemaura Medical's Total Receivables of $0.42 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Devices & Instruments company?
A good Total Receivables depends on the Medical Devices & Instruments industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Nemaura Medical and its competitors. Nemaura Medical's current Total Receivables is $0.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nemaura Medical stock overvalued right now?
Nemaura Medical (NMRD) has a current Total Receivables of $0.42 Mil. The current Total Receivables is $0.42 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Nemaura Medical (NMRD), the current Total Receivables is $0.42 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nemaura Medical Business Description

Address 57 West 57th Street, New York, NY, USA, 10019
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable, and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with an app displaying glucose readings at five-minute intervals for periods up to 24 hours.